The European Commission has approved Eisai and Biogen's Leqembi for a subset of patients with early-stage Alzheimer's disease, setting it up to become the first amyloid-targeting drug to reach the ...

The pharmaceutical landscape in 2024 was undeniably shaped by the remarkable rise of GLP-1 receptor agonists. Once primarily recognised for their role in managing type 2 diabetes, these therapies ...

A young woman who spent years on NHS waiting lists suffering from endometriosis finally borrowed the money for a hysterectomy in a private hospital. She had reached her breaking point. She couldn ...

Informed consent is a foundational element of every clinical trial. Yet, the traditional paper-based process has long been associated with delays, documentation errors, and disengaged participants.

As a psychiatric provider working with people from all walks of life, I’ve seen how serious mental health conditions, particularly bipolar I disorder (BD-I), can present differently depending on ...

Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease.

These have been dark days for the global economy, and the short-term prospects for the pharmaceutical industry look uncertain. The industry is currently undergoing change and restructuring on an ...

AstraZeneca has said it is considering a shift in the production of some medicines from Europe to the US in order to sidestep potential tariffs on imports introduced by the new US administration.

Italfarmaco's oral HDAC inhibitor Duvyzat has been recommended for approval in the EU as a treatment for Duchenne muscular dystrophy (DMD), setting it on course to become the first non-steroidal ...

Roche has picked up a CE Mark approval in the EU for an artificial intelligence algorithm that can help doctors decide whether patients presenting with acute chest pain are having a heart attack.

Castor bean tick (Ixodes ricinus) female from Hochholz-Kapellenbruch, Germany. There is currently no approved treatment for intracerebral haemorrhagic (ICH) stroke, but Belgian start-up Bioxodes ...

Global biopharmaceutical company Ascentage Pharma, specialising in haematological malignancies, has presented results from five preclinical studies at the American Association of Cancer Research ...